Now coming to using exemestane for bodybuilding – if you plan on using exemestane post pct, that is, after your anabolic steroid cycle, you must possess proper knowledge regarding the proper usage of this drug, the associated benefits, and certain tips and tricks to make the process much smoother.
Drugs containing exemestane pct, such as Arimidex or Aromasin, work as aromatase inhibitors which are usually used to treat recurring breast cancer in post menopausal women, as mentioned above. Recent studies have shown that Aromasin and other aromatase inhibitors work like a miracle drug for anyone using them after their anabolic steroid cycle. Other forms of aromatase inhibitors available in the market include LiquiAroma, which contains exemestane in liquid form.
The drug exemestane pct usually stays active for about 24 to 48 hours, which is quite good if you have used a high dose of anabolic steroids. Bodybuilders refer to this drug as aromatizable steroids, which is a justified name if you think about it. The main function of exemestane for body builders is that it inhibits estrogen production in their body due to the use of anabolic steroids, and restores the natural testosterone production levels. If any man has a high
level of estrogen in his blood, exemestane has the capability to reverse these effects and restore balance for testosterone, which is the natural male hormone. This reversal process usually takes 3 to 5 weeks to take effect.
As we have said earlier, exemestane pct containing Aromasin works as an aromatase inhibitor, which has the power to reduce estrogen levels. Aromasin itself is a comparatively new drug, so body builders still prefer to use more known brands, such as Letrozole or Arimidex. But with its effective nature, Aromasin is soon to catch up with its other competitors as a popular pct drug among body builders, who are always in search of new options to reduce their estrogen levels. The manufacturers, Pharmacia and Upjohn, simply need to ensure that there is enough stock in the market when the demand finally catches up with the predicted figures.
Granted that with other options available in the market, the demand for Aromasin is not likely to go up in the near future, but pharmaceutical companies can only hope for the best and wait. Now coming back to statistics – effect-wise, drugs like Arimidex and Letrozole reduce estrogen levels by 98%, whereas Aromasin reduces it by 85%. Granted this figure is low, but doctors are of the opinion that a 98% reduction will lead to a man losing his libido, which is not at all healthy. So in such a case, 85% seems like a decent enough figure. Bodybuilders can reduce estrogen levels, and maintain a healthy sexual life thanks to Aromasin now. When any body builder takes 25 mgs of Aromasin every day, the estrogen level in blood is left at 15%, with proper development of testosterone and insulin. When Aromasin is Nolvadex during the post steroidal cycle, the combination is considered to be perfect by doctors.
For breast cancer patients
Recent research has shown that the drug known as exemestane is a much better option for preventing recurring breast cancer than the previously used tamoxifen. This drug can quite easily be used for premenopausal women suffering from recurring breast cancer. The study also showed that Aromasin, a drug containing exemestane pct helped 93% of the total women suffering from breast cancer stay away from breast cancer for a period of five years or more. The figure was 89% in case of tamoxifen. The study included a sample size of almost 4700 women who were suffering from breast cancer and had suppressed ovarian functions. But the survival time for both exemestane and tamoxifen was similar, so no difference could be discovered there.
The research also suggested that both exemestane and tamoxifen displayed similar side effects, so no change there as well, which was actually quite disappointing for tamoxifen users who were looking for a more viable alternative for their current medication. Aromasin users suffered side effects like vaginal dryness, osteoporosis, a decreased level of libido, etc. Tamoxifen users suffered from blood clots, urinary incontinence, and hot flashes. These side effects were discovered during the research work among 4700 women, and each woman suffered from a different side effect, and some did not have to face any of these, which was a good sign altogether.
The New England Journal of Medicine published this study on the 10th of last month, the findings of which were disclosed at the annual meeting of the American Society of Clinical Oncology the month before. All findings were met with positive remarks, as they cleared up most of the doubts that existed in the pharmaceutical market pertaining to the use of exemestane pct.
Certain women suffer from a very specific type of breast cancer, which is known to hormone receptor positive. This form of breast cancer is usually induced by estrogen, the hormone. The basic job of tamoxifen is to block the estrogen and stop it from reaching the cells affected by cancer. Exemestane-containing Aromasin acts as a aromatase inhibitor that stops the conversion process of aromatase hormones into estrogen. This type of functionality was backed up by the American Cancer Society. Exemestane will only work if estrogen is not being produced by the ovaries, so only patients with suppressed ovarian functions can use this drug.
According to the American Cancer Society, aromatase inhibitors like exemestane pct are perfect for postmenopausal women suffering from breast cancer. For such women, exemestane works much better than tamoxifen than any other cancer preventive drug. Tamoxifen is perfect for women who have not gone through a menopausal phase, but for post menopausal women, the drug is not very much effective. In case of pre menopausal women, tamoxifen blocks the estrogen hormones that circulate all around the woman’s body, so as to avoid the cancer from spreading. This is good for preventing cancer in pre menopausal women. For post menopausal women however, the ACS suggests that exemestane be used to stop the overall production of estrogen all together.